Pt. Fajar Cakrawala Sumbindo
⚠️ High Risk
FEI: 3003996396 • Jakarta, Jabotabek • INDONESIA
FEI Number
3003996396
Location
Jakarta, Jabotabek
Country
INDONESIAAddress
Jln. Cipinang Bali Iii, Muara, Jakarta, Jabotabek, Indonesia
High Risk
FDA Import Risk Assessment
This firm has a significant history of FDA import refusals with notable violations.
Statistics
Score Breakdown
How is this score calculated?
Proprietary Algorithm
- 40% Violation Severity — AI-assessed (1-10)
- 30% Refusal Volume — Logarithmic scale
- 20% Recency — Decays over 5 years
- 10% Frequency — Refusals per year
© ImportRefusal.com Original Analysis
Violation Summary
FILTHY
The article is subject to refusal of admission pursuant to Section 801(a)(3) in that the article appears to consist in whole or in part of a filthy, putrid, or decomposed substance or be otherwise unfit for food.
HISTAMINE
The article appears to bear or contain histamine, a poisonous and deleterious substance in such quantity as ordinarily renders it injurious to health.
POISONOUS
The article is subject to refusal of admission pursuant to Section 801(a)(3) in that it appears to bear or contain a poisonous or deleterious substance which may render the article injurious to health. Contains:
Refusal History
| Date | Product | Violations | Division |
|---|---|---|---|
| 7/21/2004 | 16AGT45TUNA (ALBACORE, YELLOWFIN, BLUEFIN, SKIPJACK, ETC.) | Los Angeles District Office (LOS-DO) | |
| 7/21/2004 | 16AGT45TUNA (ALBACORE, YELLOWFIN, BLUEFIN, SKIPJACK, ETC.) | Los Angeles District Office (LOS-DO) | |
| 7/21/2004 | 16AGT45TUNA (ALBACORE, YELLOWFIN, BLUEFIN, SKIPJACK, ETC.) | Los Angeles District Office (LOS-DO) | |
| 7/21/2004 | 16AGT45TUNA (ALBACORE, YELLOWFIN, BLUEFIN, SKIPJACK, ETC.) | Los Angeles District Office (LOS-DO) | |
| 7/21/2004 | 16AGT45TUNA (ALBACORE, YELLOWFIN, BLUEFIN, SKIPJACK, ETC.) | Los Angeles District Office (LOS-DO) | |
| 7/21/2004 | 16AGT45TUNA (ALBACORE, YELLOWFIN, BLUEFIN, SKIPJACK, ETC.) | Los Angeles District Office (LOS-DO) | |
| 7/21/2004 | 16AGT45TUNA (ALBACORE, YELLOWFIN, BLUEFIN, SKIPJACK, ETC.) | Los Angeles District Office (LOS-DO) | |
| 7/21/2004 | 16AGT45TUNA (ALBACORE, YELLOWFIN, BLUEFIN, SKIPJACK, ETC.) | 249FILTHY | Los Angeles District Office (LOS-DO) |
| 7/21/2004 | 16AGT45TUNA (ALBACORE, YELLOWFIN, BLUEFIN, SKIPJACK, ETC.) | 249FILTHY | Los Angeles District Office (LOS-DO) |
| 9/9/2003 | 16AGT42SWORDFISH | 251POISONOUS | Los Angeles District Office (LOS-DO) |
| 9/9/2003 | 16AGT42SWORDFISH | 251POISONOUS | Los Angeles District Office (LOS-DO) |
| 9/9/2003 | 16AGT42SWORDFISH | 251POISONOUS | Los Angeles District Office (LOS-DO) |
| 9/9/2003 | 16AGT42SWORDFISH | 251POISONOUS | Los Angeles District Office (LOS-DO) |
| 9/9/2003 | 16AGT42SWORDFISH | 251POISONOUS | Los Angeles District Office (LOS-DO) |
| 9/9/2003 | 16AGT42SWORDFISH | 251POISONOUS | Los Angeles District Office (LOS-DO) |
Frequently Asked Questions
What is Pt. Fajar Cakrawala Sumbindo's FDA import refusal history?
Pt. Fajar Cakrawala Sumbindo (FEI: 3003996396) has 15 FDA import refusal record(s) in our database, spanning from 9/9/2003 to 7/21/2004.
What is an FEI number?
FEI stands for Firm Establishment Identifier. It's a unique number assigned by the FDA to identify establishments that manufacture, process, pack, or hold food, drugs, medical devices, or other FDA-regulated products. Pt. Fajar Cakrawala Sumbindo's FEI number is 3003996396.
What types of violations has Pt. Fajar Cakrawala Sumbindo received?
Pt. Fajar Cakrawala Sumbindo has been cited for 3 different violation type(s). Common FDA violations include adulteration (unsafe or unsanitary products), misbranding (incorrect or misleading labels), and regulatory non-compliance.
Where does this information about Pt. Fajar Cakrawala Sumbindo come from?
All FDA import refusal data for Pt. Fajar Cakrawala Sumbindo is sourced from the official FDA Data Dashboard (datadashboard.fda.gov), a public government database maintained by the U.S. Food and Drug Administration.
Data sourced from the FDA Data Dashboard, a public database maintained by the U.S. Food and Drug Administration.